Continuing Education Activity

Antisocial personality disorder (ASPD) encompasses a chronic pattern of disregard for the rights of others, impaired empathy, deceitfulness, impulsivity, and persistent behavioral dysfunction that often begins with conduct disorder in childhood or adolescence. This course examines the associated medical, psychiatric, legal, and social consequences that contribute to substantial morbidity, elevated mortality risk, substance use disorders, interpersonal violence, and recurrent healthcare utilization with ASPD. This activity reviews the advances in neurobiology, genetics, developmental psychology, and behavioral science that have expanded understanding of ASPD, psychopathy, and related Cluster B personality disorders while highlighting the complexity of diagnosis and long-term management. Participants will gain an in-depth understanding of diagnostic criteria, differential diagnosis, developmental risk factors, neurobiological findings, psychiatric comorbidities, and evidence-based management strategies. This activity for healthcare professionals is designed to enhance the learner's competence in identifying ASPD, performing longitudinal assessment and mental status examination, evaluating suicide risk, engaging in therapeutic communication, planning treatment, and implementing an appropriate interprofessional approach when managing this condition to reduce harmful behaviors and improve psychosocial functioning.

Objectives:

• Identify the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) diagnostic criteria for antisocial personality disorder.
• Differentiate antisocial personality disorder from other personality disorders.
• Apply evidence-based therapeutic interventions for managing antisocial personality disorder.
• Communicate with interprofessional team members to improve care coordination and outcomes in patients with antisocial personality disorder.

Access free multiple choice questions on this topic.

Introduction

Antisocial personality disorder (ASPD) is an adult diagnosis characterized by a persistent pattern of disregard for and violation of others' rights, beginning in childhood or early adolescence. Individuals with ASPD often manipulate others for personal gain, lack empathy, and seldom feel remorse for their actions. They struggle to develop stable interpersonal relationships and experience significant impairments in social and occupational functioning throughout their lives. Legal issues frequently arise from their repeated failure to learn from the repercussions of their behavior, often involving criminal acts.[1]

Antisocial behaviors exist on a spectrum. Conduct disorder, a childhood-specific condition, manifests as a repetitive and persistent pattern of behavior that violates the fundamental rights of others or major societal norms or rules. Children with conduct disorder may exhibit aggression toward people or animals, destruction of property, deceitfulness, theft, or other serious rule violations.[2] The trajectory of youth diagnosed with conduct disorder varies, with males being more likely than females to progress to ASPD in adulthood.[3][4]

While most children with conduct disorder will not develop ASPD, conduct disorder is a significant risk factor for its development.[5] Psychopathy is also a distinct clinical construct.[6] Psychopathy is a related but distinct clinical construct. While most individuals meeting the criteria for psychopathy also meet the criteria for ASPD, the reverse is not true. ASPD is defined primarily by behavioral criteria (eg, criminal acts, irresponsibility), whereas psychopathy also includes core affective and interpersonal deficits, eg, a lack of empathy, grandiosity, and shallow affect. Therefore, psychopathy is often considered a more severe construct with a stronger prediction for instrumental violence.[6][7] Robert Hare's Psychopathy Checklist-Revised (PCL-R) is an assessment tool designed to measure psychopathic traits, contributing to a more nuanced understanding of psychopathy and its connection to ASPD.[7]

The roots of our understanding of antisocial personality disorder trace back to the 19th century, when French physician Philippe Pinel (1745-1826) and French psychiatrist Jean Etienne Dominique Esquirol (1772-1840) made significant observations of individuals exhibiting behaviors consistent with ASPD.[8] Their descriptions noted chronic antisocial behaviors and a lack of empathy or remorse.[9]

In the early 20th century, American psychiatrist Hervey Cleckley (1903-1984) and, later, Canadian psychologist Robert Hare (1934-) delved into the concept of psychopathy.[7] Cleckley's seminal work, The Mask of Sanity (1941), laid the foundation for comprehending psychopathy as a distinct psychological construct.[10] The terms "psychopath" and "sociopath" were often used interchangeably to describe individuals displaying traits associated with ASPD.[11]

The Diagnostic and Statistical Manual of Mental Disorders (DSM) first introduced ASPD in its third edition (1980), initially emphasizing persistent patterns of antisocial behaviors beginning in adolescence or early adulthood. The DSM-5 revised the diagnostic criteria, highlighting the importance of behaviors that reflect a disregard for the rights of others. This emphasis persists in the current Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR).[12]

The DSM-5-TR divides personality disorders into clusters A, B, and C. Each cluster encompasses the following distinct set of personality disorders with commonalities in symptoms, behaviors, and underlying psychological patterns:

• Cluster A: Characterized by odd or eccentric traits. It includes paranoid, schizoid, and schizotypal personality disorders. Individuals often exhibit social withdrawal, peculiar or paranoid beliefs, and difficulties forming close relationships.
• Cluster B: Comprises personality disorders with dramatic, emotional, or erratic behaviors. It includes antisocial, borderline (BPD), histrionic, and narcissistic (NPD) personality disorders. Individuals often exhibit impulsive behavior, emotional instability, and difficulty maintaining stable relationships.
• Cluster C: Characterized by anxious and fearful traits. It includes avoidant, dependent, and obsessive-compulsive personality disorders. Individuals often experience significant anxiety, fear of abandonment, and an excessive need for control or perfectionism.[13]

Although the cluster system provides a historical framework, its clinical validity is not consistently supported by the literature, and the cluster system has known limitations.[14]

Etiology

The development of ASPD is multifactorial. Research on its etiology is limited, and high-quality studies investigating its specific causes are scarce. Factors, eg, genetic predisposition, childhood experiences, and environmental influences, likely contribute to the development of ASPD; however, the clinical significance of these factors remains unclear.[15]

Personality Development

Personality is a complex summation of biological, psychological, social, and developmental factors, making each person's personality unique, even among those with a personality disorder. Personality is a pattern of behaviors that an individual develops in response to constantly changing internal and external stimuli. A person's temperament broadly refers to consistent, biologically based individual differences in behavior that are relatively independent of learning.[16][17]

Temperament develops further through epigenetic mechanisms, particularly through life experiences, eg, trauma and socioeconomic conditions. These are considered adaptive etiological factors in personality development.[18][19] Temperament domains include:

• Harm avoidance: Involves a bias toward inhibiting behavior to avoid punishment or nonreward.[20] Individuals with ASPD have low harm avoidance.
• Novelty seeking: An inherent desire to initiate novel activities that are likely to produce a reward signal.[21] Individuals with ASPD exhibit high levels of novelty-seeking behaviors.
• Reward dependence: Describes the desire to alter behaviors in response to social reward cues.[22] Individuals with ASPD have low reward dependence.
• Persistence: Refers to the ability to maintain effort and continue with behaviors despite obstacles, frustration, or limited reinforcement.[22] Individuals with ASPD exhibit low persistence and are prone to abandoning pursuits when faced with challenges.

Genetic Etiologies

Genetic studies suggest a hereditary component to personality disorders, including ASPD. Twin studies have found a monozygotic concordance rate of 67% compared with 31% in dizygotic twins.[23] Family studies estimate that 20% of individuals with ASPD have a first-degree relative with the disorder.[24] A twin study involving 1,048 subjects found a shared common heritability factor of 0.81 for substance use disorder, ASPD, and disinhibition.[25] Another twin study with 2,794 subjects revealed a 51% common-factor heritability for ASPD behaviors.[26]

A landmark study of male children who experienced abuse demonstrated a key gene-environment interaction (GxE). A functional polymorphism in the gene encoding monoamine oxidase A (MAO-A) moderated the effect of maltreatment on the development of antisocial behavior. Specifically, maltreated children with the low-activity variant of the MAO-A gene were significantly more likely to develop conduct disorder and ASPD.[27] Those with low levels of MAO-A expression were more likely to develop the disorder.[27] Children who experienced the same levels of abuse but had the high-activity variant of the gene were not more likely to develop ASPD.

Serotonin may inhibit impulsive and violent behaviors. A genetic variant in tryptophan hydroxylase is thought to influence 5-hydroxyindoleacetic acid (5-HIAA) concentrations, contributing to low 5-HIAA levels in the cerebrospinal fluid (CSF).[28] Low CSF levels of 5-HIAA, the major metabolite of serotonin, are associated with violent, suicidal, and impulsive behaviors.[29][30]

Neurodevelopment Etiologies

Medical conditions that damage neurons are often associated with personality disorders or changes, including head trauma, cerebrovascular diseases, cerebral tumors, epilepsy, Huntington's disease, multiple sclerosis, endocrine disorders, heavy metal poisoning, neurosyphilis, and AIDS.[31] Subclinical brain injury in utero due to maternal tobacco smoke exposure, drug use, or starvation has been proposed as a predisposing factor for antisocial behavior.[32] Chemicals from tobacco and lower oxygen levels may contribute to neuronal injury in the developing fetus.[32][33]

Family and Psychosocial Factors 

Various psychoanalytic factors are believed to contribute to the development of personality traits and disorders, including unconscious processes, early childhood experiences, and internal conflicts.[34]

Psychoanalyst Wilhelm Reich (1897-1957) contributed significantly to understanding defense mechanisms, introducing the concept of "character armor." This refers to defense mechanisms that develop to alleviate cognitive conflict arising from internal impulses and interpersonal anxiety.[35] For instance, those with antisocial tendencies often use defense mechanisms, eg, displacement, denial, projection, rationalization, and regression.[36]

Parenting styles likely contribute to the development of ASPD. Adult antisocial traits are associated with experiences of parental neglect and abuse.[37] Children who experience abuse or neglect may be more predisposed to developing ASPD.[38] One study estimates that 14% to 21% of adults who report abusing their children are affected by ASPD.[39] Peer relations during childhood and adolescence also impact personality development. Youth with traits of conduct disorder are more likely to engage with peers who have similar qualities, and peer conflict has been identified as a key mechanism for future antisocial behavior.[40][41]

The role of exposure to violent media through television, music, and video games is a common concern. Current data are conflicting but suggest that individuals already prone to developing ASPD are likely to do so regardless of their exposure to media violence.[42][43][44]

Epidemiology

The estimated prevalence of ASPD in the general population is 2% to 3%. These estimates often lack data on incarcerated or institutionalized individuals. Studies from the late 1990s revealed ASPD rates as high as 80% in male inmates and up to 60% in female inmates.[45] The prevalence of ASPD in United States prisons may be declining, possibly due to increasingly harsh sentencing laws. A more recent study revealed an ASPD incidence of 35% in incarcerated males.[46] The National Epidemiologic Survey on Alcohol and Related Conditions found the risk of ASPD was 3 times greater in males than in females,[47] with some estimates placing the risk at 5 times greater.[48]

The prevalence of ASPD in patients with alcohol use disorder ranges from 16% to 49%.[45] Homelessness is also associated with ASPD. ASPD is linked with a lower socioeconomic status, possibly as a consequence of the inability to maintain a job, pay rent, and comorbid substance use disorders. Higher education is negatively correlated with ASPD, and ASPD is more prevalent among those with lower IQs and reading levels.[48][49][50] Additional psychiatric disorders are commonly associated with ASPD, including substance use disorders, mood and anxiety disorders, attention deficit hyperactivity disorder (ADHD), learning disorders, gambling disorders, and other personality disorders like BPD.

Pathophysiology

Underarousal of the autonomic nervous system is suggested as the underlying pathophysiology in some individuals with ASPD. This hypothesis proposes that these individuals require higher sensory input than typical subjects to achieve normal brain functioning. This may cause them to seek high-arousal situations to raise their arousal to more tolerable levels, resulting in higher risk tolerance.[51][52] Findings that support this hypothesis include lower pulse rates, lower skin conductance, and increased amplitude on event-related potentials in patients with ASPD.[30][53]

Furthermore, nearly 50% of individuals with ASPD exhibit various electroencephalogram (EEG) abnormalities, including more slow-wave activity.[52][54] Individuals with ASPD have a higher occurrence of minor facial abnormalities and, in childhood, a higher incidence of learning disorders, ADHD, and persistent enuresis.[52][54]

Researchers have identified structural and functional abnormalities in key brain circuits. These include deficits in the fronto-limbic network, which is critical for emotion regulation, fear conditioning, and decision-making. Key regions implicated include the prefrontal cortex (particularly the orbitofrontal and ventromedial regions), the amygdala, the hippocampus, and the anterior cingulate cortex.[55] Examples of findings associated with abnormalities in these regions include:

• Low glucose metabolism in the right temporal lobe on positron emission tomography (PET) in individuals with a violent military history.[56] 
• A study comparing 21 individuals with ASPD to 34 control subjects showed reduced prefrontal gray matter on structural magnetic resonance imaging (MRI).[57]
• In a study comparing 18 men with ASPD and psychopathy to healthy controls, a smaller orbitofrontal cortex volume was observed using structural MRI.[47]

History and Physical

The presentation of ASPD is variable, making a thorough history of the condition, medical history, and social history essential. A history of childhood behavior is necessary, as evidence of conduct disorder must be present to diagnose ASPD. Approximately 80% of patients with ASPD exhibit antisocial traits by age 11, although some behaviors can appear as early as preschool.[58]

Common childhood behaviors include fighting, conflict with parents and authority figures, stealing, vandalism, fire-setting, cruelty to animals, school behavioral problems, poor academic performance, and running away.[58] Asking an adult with suspected ASPD about any history with the juvenile detention system or other early-life criminal activity can help determine if conduct disorder was present. Collateral information from family and friends is also helpful, as they may be more accurate historians than individuals with ASPD.[59]

As individuals with ASPD age, similar behavior patterns manifest in new, age-appropriate ways. Typical findings include poor job performance, lack of responsibility, and frequent job changes or firings. Additionally, affected patients may use aliases and other deceitful behaviors to manipulate people. Sexual promiscuity and unstable relationships, often coupled with physical or emotional abuse of their partners, lead to high rates of separation and divorce.[60]

Antisocial actions can vary greatly, from minor acts like lying and stealing to extreme acts, eg, sexual assault and murder. Obtaining a timeline of an individual's incarceration history can help establish a pattern of behavior over their lifetime. ASPD should be considered in the differential diagnosis when a patient presents with drug-seeking behavior, signs of malingering, injuries from reckless behavior, recurrent sexually transmitted diseases, or evidence of abuse.[61][62][63]

The mental status examination is crucial in assessing individuals with ASPD, given their propensity to manipulate, lie, or use aliases.[61] The findings are unique to each individual. The assessment should include:

• Appearance: Clinicians should note the patient's general grooming and appearance. Individuals with ASPD may have minor facial anomalies or tattoos, some of which could be associated with gang affiliation.[54][64] Although tattoos alone are not indicative of pathology, individuals with ASPD tend to have more tattoos covering a larger total body surface area.[65]

• Behavior: Behavior is likely to vary depending on the context and the individual's current goals and can be manipulative, disinhibited, aggressive, or deceitful.

• Speech: Individuals with ASPD do not generally have problems with speech initiation or vocabulary.

• Affect: Affect varies, and frustration tolerance is generally low, leading to a higher propensity for anger.

• Thought content: Assessing suicide and homicide risk is essential. Delusions are not consistent with ASPD, but comorbid substance use may cause psychotic symptoms, including delusions.

• Perceptions: Hallucinations are not a feature of ASPD, but they may be experienced as a result of substance use.

• Thought process: Individuals with ASPD generally have a linear thought process, but may have a limited range and logic. They consistently fail to plan ahead or learn from past mistakes.

• Cognition: General cognition and orientation are typically unimpaired.

• Insight: Individuals with ASPD typically have poor insight and show little or no remorse for how their actions impact their social and occupational functioning.

• Judgment and impulse control: Individuals with ASPD generally exhibit poor judgment and impulse control.

Evaluation

Diagnosing a personality disorder involves a longitudinal observation of a patient's behaviors across various circumstances to gain a broad understanding of long-term functioning.[66] Because many personality disorder features can overlap with symptoms of acute psychiatric conditions, a personality disorder should not be diagnosed during an acute episode when possible. However, longitudinal observation may not always be feasible, particularly when an underlying personality disorder significantly contributes to hospitalizations or the relapse of another psychiatric condition, eg, a major depressive episode.[67] Establishing a firm diagnosis of ASPD will likely require several visits with a patient.

Psychological testing can help diagnose personality disorders but is not typically necessary for ASPD if a sufficient history is available. Psychological testing may be useful when collateral information or a history of childhood behavior is unavailable, or if the patient is uncooperative.[68] The Minnesota Multiphasic Personality Inventory (MMPI) can assess personality functioning, with higher scores on psychopathic deviance patterns suggesting ASPD.[69] For severe ASPD, the Psychopathy Personality Inventory (PPI) is another potentially helpful tool.[70]

To receive a formal diagnosis of ASPD, individuals must meet the diagnostic criteria specified in the DSM-5-TR. The diagnosis involves a thorough evaluation that considers multiple sources of information, including personal history, collateral information, and a mental status examination.

Antisocial Personality Disorder DSM-5-TR Criteria 

The DSM-5-TR uses the following criteria to diagnose ASPD:

1. A pervasive pattern of disregard for and violation of the rights of others, occurring since age 15 years, as indicated by 3 (or more) of the following:

   1. Failure to conform to social norms concerning lawful behaviors, as indicated by repeatedly performing acts that are grounds for arrest.
   2. Deceitfulness, as indicated by repeated lying, use of aliases, or conning others for personal profit or pleasure.
   3. Impulsivity or failure to plan ahead.
   4. Irritability and aggressiveness, as indicated by repeated physical fights or assaults.
   5. Reckless disregard for the safety of self or others.
   6. Consistent irresponsibility, as indicated by repeated failure to sustain consistent work behavior or honor financial obligations.
   7. Lack of remorse, as indicated by being indifferent to or rationalizing having hurt, mistreated, or stolen from another.
2. The individual is at least 18 years old.
3. Evidence is present of conduct disorder with onset before age 15 years.
4. The occurrence of antisocial behavior is not exclusively during the course of schizophrenia or bipolar disorder.

Adults who do not have evidence of conduct disorder in childhood but otherwise meet the criteria for ASPD can be diagnosed with adult antisocial behavior. While this is not a formal DSM-5-TR diagnosis, the diagnosis is listed as a "V code" (in ICD-9) or "Z code" (in ICD-10), which are used to identify factors influencing a patient's health status.

Treatment / Management

No standard treatment algorithm exists for ASPD, despite numerous interventions having been tested. Early treatment for children with conduct disorder is considered the most effective and least costly way to prevent or treat ASPD.[71] Often, patients seek treatment at the behest of a family member or friend. This typically occurs after maladaptive behaviors have caused stress for others, rather than due to any internal distress experienced by the individual with ASPD. Therefore, assessing the treatment goals in each case is essential. Since ASPD is unlikely to remit, treatment should focus on reducing interpersonal conflict and stabilizing psychosocial functioning.[72][73] Case management can assist patients in maintaining income, securing shelter, and accessing medical and mental health services.

Patients with ASPD frequently present due to comorbid psychiatric conditions. In the absence of comorbid illness, limited evidence indicates that pharmacotherapy is effective for ASPD. Treatment should begin with standard therapy for the comorbid diagnosis.

If the patient is also experiencing violent behavior, a trial of a second-generation antipsychotic for 8 to 12 weeks is an acceptable choice. If this is not helpful, a trial of another second-generation antipsychotic may be considered. If still not beneficial, medications may be trialed to target specific symptoms. For example, an SSRI may be considered for impulsivity and affective instability, while mood stabilizers like lithium or carbamazepine have been used to target aggression and severe mood lability.[74][Black, DW. Antisocial Personality Disorder. Gabbard's Treatments of Psychiatric Disorders (5th ed). 2014] Patients with a history of head trauma may benefit from propranolol, buspirone, or trazodone. However, evidence for these medications is limited and inconsistent, and none are FDA-approved for the treatment of ASPD.[75][76][77][78][79][80] Benzodiazepines and stimulants should be avoided due to the risk of abuse, addiction, and behavioral disinhibition.[81] 

Psychotherapy for ASPD has limited evidence of efficacy, in large part due to poor patient motivation, lack of insight, and difficulty forming a therapeutic alliance. The goal is typically not a "cure" but rather harm reduction, management of problematic behaviors (eg, aggression), and improvement of psychosocial functioning. Psychotherapy techniques include:

• Cognitive behavioral therapy (CBT): may be used to challenge antisocial beliefs and thinking patterns (cognitive distortions) and develop prosocial skills, though outcomes are mixed
• Mentalization-based treatment (MBT): used particularly for patients with comorbid BPD, aims to improve the ability to understand the mental states of oneself and others, which may reduce interpersonal conflict [73]
• Transference-focused psychotherapy (TFP): has been explored, particularly for patients with comorbid narcissistic features, focusing on the distorted perceptions of self and others that emerge in the therapeutic relationship [82][83]

Hospitalization is not cost-effective, as it provides little to no benefit for those with ASPD. Additionally, the behavior of patients with ASPD in a psychiatric hospital can disrupt the therapeutic environment for other patients. Hospitalization should be reserved for treating concurrent psychiatric conditions or complications, such as substance intoxication or withdrawal, or recent suicidal behavior.[84]

Patients with Cluster B personality disorders may display transference, a projection of their prior conflicts onto the clinician. In turn, clinicians may develop countertransference, projecting their own unresolved conflicts onto the patient.[85] Clinicians must recognize signs of countertransference to mitigate any treatment bias that may affect patient care.[86] Sublimation, a defense mechanism that transforms unwanted impulses into less harmful ones, can be a useful clinical tool. When clinicians feel frustrated, they can sublimate these negative countertransference feelings and use them to guide the differential diagnosis toward a personality disorder, which can inform the treatment plan.[87]

Differential Diagnosis

The differential diagnoses for ASPD include:

• Borderline personality disorder (BPD)
• Narcissistic personality disorder (NPD)
• Substance use disorders
• Substance-induced antisocial behavior
• Psychotic or mood disorders (eg, bipolar disorder)
• Intermittent explosive disorder
• Medical conditions (eg, temporal lobe epilepsy, brain tumor, cerebrovascular accident)
• Isolated acts of misbehavior

Many behaviors in ASPD overlap with symptoms of other psychiatric illnesses, so assessing if ASPD occurs in isolation or with another condition is critical. Irritability and aggression can occur in psychotic and bipolar spectrum illnesses. However, isolated ASPD is not associated with a decreased need for sleep, and the behavioral patterns are chronic rather than episodic, eg, manic or hypomanic episodes. ASPD is also largely unresponsive to medications that are effective for mood and psychotic disorders.[88]

A thorough history is generally sufficient to distinguish ASPD from isolated acts of misbehavior, which are inconsistent with long-term antisocial traits. Intermittent explosive disorder involves isolated episodes of assaultive and destructive behavior but is not associated with a history of conduct disorder or the broader impairments seen in ASPD. Intermittent explosive disorder cannot be diagnosed as a comorbid condition with ASPD.[89]

ASPD can be differentiated from BPD, as BPD is associated with much greater internal conflict, eg, fear of abandonment, identity issues, and frequent mood swings.[90] ASPD differs from NPD in that individuals with NPD are generally not as aggressive and can be more compassionate, although both share traits of deceitfulness and exploitation.[91]

Additionally, chronic alcohol and drug use can contribute to antisocial behaviors. Differentiating this from ASPD, where the antisocial pattern persists through states of both intoxication and sobriety, is important.

Pertinent Studies and Ongoing Trials

High-quality population studies are lacking in the field of personality disorders. Significant limitations exist in the current models used to describe these disorders. The DSM's cluster system is the most commonly utilized framework, but the uniqueness of each individual remains a barrier to diagnosis and research.[14]

Many experts in personality disorders suggest switching to a dimensional model of personality rather than a categorical cluster model. Proposed dimensional models generally describe temperament, defense mechanisms, and pathological personality traits.[92] Although the DSM-5 did not incorporate these recommendations due to the radical change it would have represented for clinical practice, the paradigm will likely shift in the coming decades as research solidifies and clinical guidelines evolve. This trend is evident in the "Emerging Measures and Models" section of the DSM-5-TR. In this section, some of the "cluster" model personality disorders have been removed, but ASPD remains a named personality disorder.

Prognosis

ASPD is typically a lifelong condition that is refractory to treatment. Nearly 25% of girls and 40% of boys diagnosed with conduct disorder eventually develop ASPD. As patients age into their 30s and 40s, a notable percentage (some studies suggest around 30%) show a reduction in overt antisocial and criminal behaviors. However, this 'burnout' does not necessarily mean a resolution of underlying personality traits, eg, deceitfulness or lack of empathy; rather, the expression of these traits may become less overtly violent or illegal. This is reflected in crime rates, which peak in severity and frequency at younger ages. Past studies have revealed remission rates of 12% to 27%, but many patients remain symptomatic, and some never improve.

In patients who achieve remission, the mean age is 35. Those with less severe baseline symptomatology show better remission rates. Individuals with a later onset of antisocial behavior tend to manifest fewer severe behavioral problems. Interestingly, individuals who were either never imprisoned or imprisoned for extended periods had higher remission rates than those detained for shorter periods.[93] Factors that predict better outcomes include older age at presentation, stronger community ties, job stability, and marital attachment.[94][95]

Complications

Individuals with a personality disorder face a heightened risk of suicide and suicide attempts. Regular screening for suicidal ideation is necessary for individuals with ASPD.[96] ASPD is a predictor for overall mortality, likely due to factors, eg, neglect of medical conditions, noncompliance with treatment, or inadequate health insurance. Those with ASPD also have an increased incidence of death from accidents, suicides, or homicides.[96]

Patients with personality disorders commonly exhibit substance use disorders.[96] Due to the elevated risk associated with high-risk sexual and substance use behaviors in individuals with ASPD, regular medical evaluations are essential. These evaluations can help identify and address potential medical conditions, including sexually transmitted infections, infectious diseases like hepatitis C from intravenous drug use, and physical traumas resulting from reckless behaviors.[96]

Deterrence and Patient Education

ASPD is characterized by a persistent pattern of socially irresponsible, exploitative, and guiltless behavior. Symptoms typically emerge in childhood or early adolescence and are fully evident by the late 20s or early 30s. The disorder tends to be lifelong and to disrupt various aspects of life, including family relationships, school, and work.

Key behaviors include engaging in criminal activities, struggling to maintain consistent employment, manipulating others for personal gain, and having difficulty establishing stable relationships. Individuals with ASPD often lack empathy, rarely experience remorse, and consistently fail to learn from negative experiences. The cause of ASPD is multifactorial, with genetic, socioeconomic, and neurodevelopmental factors all playing a role.

Patients with ASPD often present due to a coexisting psychiatric illness, and treatment should begin by addressing that illness. Various medications have shown inconsistent results in treating ASPD itself. Most importantly, individuals with ASPD require a safe and supportive therapeutic environment. Patients should be encouraged to express the symptoms they wish to have addressed and to communicate any psychosocial stressors that a treatment team can help alleviate. Rather than focusing on changing the patient's worldview, clinicians should aim to understand and address the specific challenges the patient is facing, particularly when the patient is not in acute distress.[97]

Involving the patient's family is another way to monitor for decompensation and to provide education on creating stabilizing social factors for the patient.[97] Using standardized quality-of-life assessments may reveal ways to optimize the patient's functional ability.[98] Additionally, the symptoms of ASPD often decrease with age. A more promising outlook is associated with older age at presentation, improved community ties, job stability, and marital attachment. While some patients achieve remission, others will only improve, and some will remain symptomatic with no improvement. Patients with ASPD are at an increased risk of death due to suicide, homicide, and accidents, and they warrant close surveillance by their healthcare team.

Pearls and Other Issues

Key points to remember about ASPD include the following:

• ASPD is a personality disorder characterized by a pervasive pattern of disregard for and violation of the rights of others, beginning in childhood or adolescence.
• The diagnosis requires evidence of conduct disorder before age 15 and is based on specific criteria outlined in the DSM-5-TR.
• Individuals with ASPD often engage in manipulation, exploitation, and criminal activity, disregarding social norms and laws.
• ASPD commonly co-occurs with other mental health conditions, eg, substance use disorders, mood disorders, and other personality disorders.
• ASPD is often chronic and resistant to treatment, but some individuals may show improvement with age, particularly a reduction in impulsivity and aggressiveness.
• Risk factors include a history of childhood abuse or neglect, genetic predisposition, and environmental factors, eg, a dysfunctional family environment.
• Management involves psychotherapy, particularly CBT, aimed at addressing maladaptive behaviors. Medications may target specific symptoms or comorbid conditions, but no specific pharmacological treatment has been developed for ASPD.
• Drug-seeking behaviors are common, particularly in institutional settings.[99] These behaviors may include malingering and other deceitful actions to obtain medications with abuse potential.[100] In correctional settings, psychiatric medications are commonly diverted for abuse, often via alternate routes of administration. Reports exist of nasal insufflation of buspirone inducing psychosis and euphoria sensations exist.[101][102] Similarly, abuse of bupropion and quetiapine has also been reported.[101][103][104][105][106]

Enhancing Healthcare Team Outcomes

ASPD is a chronic psychiatric condition characterized by persistent disregard for the rights of others, deceitfulness, impulsivity, aggression, irresponsibility, and lack of remorse beginning in childhood or adolescence as conduct disorder. ASPD is associated with substantial psychiatric, medical, legal, and social morbidity, including accidental death, suicide, homicide, substance use disorders, violence, recurrent injuries, sexually transmitted infections, incarceration, and elevated mortality risk. Pathophysiology involves complex interactions among genetic predisposition, neurodevelopmental abnormalities, environmental trauma, maladaptive psychosocial influences, and dysfunction within fronto-limbic brain circuits involved in emotional regulation and decision-making. Diagnosis requires longitudinal assessment using DSM-5-TR criteria, collateral history, mental status examination, and evaluation for comorbid psychiatric and medical conditions. Management focuses on reducing harmful behaviors, treating coexisting psychiatric disorders, improving psychosocial functioning, and monitoring suicide and violence risk through individualized pharmacologic and psychotherapeutic interventions.

Interprofessional collaboration improves safety, continuity of care, and long-term outcomes for individuals with ASPD through coordinated assessment, treatment planning, and monitoring. Psychiatrists, psychologists, primary care clinicians, and advanced practitioners collaborate to establish accurate diagnoses, evaluate comorbid conditions, manage pharmacotherapy, and coordinate referrals for psychotherapy, substance use treatment, and social services. Nurses contribute ongoing behavioral assessment, medication monitoring, patient education, and risk surveillance for suicidality, aggression, and treatment nonadherence. Pharmacists identify medication interactions, monitor adverse effects, and reinforce safe prescribing practices, particularly given the risks associated with benzodiazepines and stimulants. Social workers, case managers, and community mental health professionals facilitate housing support, access to healthcare resources, legal coordination, and follow-up care. Effective communication, shared decision-making, trauma-informed care, and timely referral strategies strengthen therapeutic alliances, reduce preventable complications, and support systems-based management of this high-risk population.

Review Questions

• Access free multiple choice questions on this topic.
• Click here for a simplified version.
• Comment on this article.

References

1.

Clark DA, Donnellan MB, Robins RW. Antisocial Traits, Negative Emotionality, and Trajectories of Relationship Quality in Mexican-Origin Couples. J Pers Disord. 2020 Aug;34(4):459-479. [PubMed: 31403390]

2.

Mohan L, Yilanli M, Deniz I, Ray S. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Jul 10, 2023. Conduct Disorder. [PubMed: 29261891]

3.

Junewicz A, Billick SB. Conduct Disorder: Biology and Developmental Trajectories. Psychiatr Q. 2020 Mar;91(1):77-90. [PubMed: 31768912]

4.

Gelhorn HL, Sakai JT, Price RK, Crowley TJ. DSM-IV conduct disorder criteria as predictors of antisocial personality disorder. Compr Psychiatry. 2007 Nov-Dec;48(6):529-38. [PMC free article: PMC2764329] [PubMed: 17954138]

5.

Sagar R, Patra BN, Patil V. Clinical Practice Guidelines for the management of conduct disorder. Indian J Psychiatry. 2019 Jan;61(Suppl 2):270-276. [PMC free article: PMC6345126] [PubMed: 30745702]

6.

Coid J, Ullrich S. Antisocial personality disorder is on a continuum with psychopathy. Compr Psychiatry. 2010 Jul-Aug;51(4):426-33. [PubMed: 20579518]

7.

Hare RD, Neumann CS. Psychopathy as a clinical and empirical construct. Annu Rev Clin Psychol. 2008;4:217-46. [PubMed: 18370617]

8.

Charland LC. Science and morals in the affective psychopathology of Philippe Pinel. Hist Psychiatry. 2010 Mar;21(81 Pt 1):38-53. [PubMed: 21877429]

9.

Kendler KS. Philippe Pinel and the foundations of modern psychiatric nosology. Psychol Med. 2020 Dec;50(16):2667-2672. [PubMed: 33213600]

10.

Crego C, Widiger TA. Cleckley's psychopaths: Revisited. J Abnorm Psychol. 2016 Jan;125(1):75-87. [PubMed: 26618655]

11.

Lilienfeld SO, Watts AL, Smith SF, Patrick CJ, Hare RD. Hervey Cleckley (1903-1984): Contributions to the study of psychopathy. Personal Disord. 2018 Nov;9(6):510-520. [PubMed: 30080062]

12.

First MB, Yousif LH, Clarke DE, Wang PS, Gogtay N, Appelbaum PS. DSM-5-TR: overview of what's new and what's changed. World Psychiatry. 2022 Jun;21(2):218-219. [PMC free article: PMC9077590] [PubMed: 35524596]

13.

Hopwood CJ, Thomas KM, Markon KE, Wright AG, Krueger RF. DSM-5 personality traits and DSM-IV personality disorders. J Abnorm Psychol. 2012 May;121(2):424-32. [PMC free article: PMC3909514] [PubMed: 22250660]

14.

Tackett JL, Silberschmidt AL, Krueger RF, Sponheim SR. A dimensional model of personality disorder: incorporating DSM Cluster A characteristics. J Abnorm Psychol. 2008 May;117(2):454-9. [PubMed: 18489222]

15.

DeLisi M, Drury AJ, Elbert MJ. The etiology of antisocial personality disorder: The differential roles of adverse childhood experiences and childhood psychopathology. Compr Psychiatry. 2019 Jul;92:1-6. [PubMed: 31079021]

16.

Sanchez-Roige S, Gray JC, MacKillop J, Chen CH, Palmer AA. The genetics of human personality. Genes Brain Behav. 2018 Mar;17(3):e12439. [PMC free article: PMC7012279] [PubMed: 29152902]

17.

Réale D, Reader SM, Sol D, McDougall PT, Dingemanse NJ. Integrating animal temperament within ecology and evolution. Biol Rev Camb Philos Soc. 2007 May;82(2):291-318. [PubMed: 17437562]

18.

Svrakic DM, Cloninger RC. Epigenetic perspective on behavior development, personality, and personality disorders. Psychiatr Danub. 2010 Jun;22(2):153-66. [PubMed: 20562740]

19.

Gescher DM, Kahl KG, Hillemacher T, Frieling H, Kuhn J, Frodl T. Epigenetics in Personality Disorders: Today's Insights. Front Psychiatry. 2018;9:579. [PMC free article: PMC6252387] [PubMed: 30510522]

20.

Wan L, Zha R, Ren J, Li Y, Zhao Q, Zuo H, Zhang X. Brain morphology, harm avoidance, and the severity of excessive internet use. Hum Brain Mapp. 2022 Jul;43(10):3176-3183. [PMC free article: PMC9188967] [PubMed: 35332975]

21.

Gocłowska MA, Ritter SM, Elliot AJ, Baas M. Novelty seeking is linked to openness and extraversion, and can lead to greater creative performance. J Pers. 2019 Apr;87(2):252-266. [PubMed: 29604214]

22.

Frank GKW, Shott ME, Sternheim LC, Swindle S, Pryor TL. Persistence, Reward Dependence, and Sensitivity to Reward Are Associated With Unexpected Salience Response in Girls but Not in Adult Women: Implications for Psychiatric Vulnerabilities. Biol Psychiatry Cogn Neurosci Neuroimaging. 2022 Nov;7(11):1170-1182. [PubMed: 33872764]

23.

Brennan PA, Mednick SA. Genetic perspectives on crime. Acta Psychiatr Scand Suppl. 1993;370:19-26. [PubMed: 8452051]

24.

Guze SB, Wolfgram ED, McKinney JK, Cantwell DP. Psychiatric illness in the families of convicted criminals: a study of 519 first-degree relatives. Dis Nerv Syst. 1967 Oct;28(10):651-9. [PubMed: 6051292]

25.

Krueger RF, Hicks BM, Patrick CJ, Carlson SR, Iacono WG, McGue M. Etiologic connections among substance dependence, antisocial behavior, and personality: modeling the externalizing spectrum. J Abnorm Psychol. 2002 Aug;111(3):411-24. [PubMed: 12150417]

26.

Rosenström T, Ystrom E, Torvik FA, Czajkowski NO, Gillespie NA, Aggen SH, Krueger RF, Kendler KS, Reichborn-Kjennerud T. Genetic and Environmental Structure of DSM-IV Criteria for Antisocial Personality Disorder: A Twin Study. Behav Genet. 2017 May;47(3):265-277. [PMC free article: PMC5404958] [PubMed: 28108863]

27.

Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, Taylor A, Poulton R. Role of genotype in the cycle of violence in maltreated children. Science. 2002 Aug 02;297(5582):851-4. [PubMed: 12161658]

28.

Nielsen DA, Goldman D, Virkkunen M, Tokola R, Rawlings R, Linnoila M. Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Arch Gen Psychiatry. 1994 Jan;51(1):34-8. [PubMed: 7506517]

29.

da Cunha-Bang S, Knudsen GM. The Modulatory Role of Serotonin on Human Impulsive Aggression. Biol Psychiatry. 2021 Oct 01;90(7):447-457. [PubMed: 34266672]

30.

Scarpa A, Raine A. Psychophysiology of anger and violent behavior. Psychiatr Clin North Am. 1997 Jun;20(2):375-94. [PubMed: 9196920]

31.

Leppla I, Fishman D, Kalra I, Oldham MA. Clinical Approach to Personality Change Due to Another Medical Condition. J Acad Consult Liaison Psychiatry. 2021 Jan-Feb;62(1):14-21. [PubMed: 33190792]

32.

Neugebauer R, Hoek HW, Susser E. Prenatal exposure to wartime famine and development of antisocial personality disorder in early adulthood. JAMA. 1999 Aug 04;282(5):455-62. [PubMed: 10442661]

33.

Wakschlag LS, Lahey BB, Loeber R, Green SM, Gordon RA, Leventhal BL. Maternal smoking during pregnancy and the risk of conduct disorder in boys. Arch Gen Psychiatry. 1997 Jul;54(7):670-6. [PubMed: 9236551]

34.

Newlin E, Weinstein B. Personality disorders. Continuum (Minneap Minn). 2015 Jun;21(3 Behavioral Neurology and Neuropsychiatry):806-17. [PubMed: 26039856]

35.

Shapiro D. Theoretical reflections on Wilhelm Reich's Character Analysis. Am J Psychother. 2002;56(3):338-46. [PubMed: 12400201]

36.

Di Giuseppe M, Perry JC. The Hierarchy of Defense Mechanisms: Assessing Defensive Functioning With the Defense Mechanisms Rating Scales Q-Sort. Front Psychol. 2021;12:718440. [PMC free article: PMC8555762] [PubMed: 34721167]

37.

Reti IM, Samuels JF, Eaton WW, Bienvenu OJ, Costa PT, Nestadt G. Adult antisocial personality traits are associated with experiences of low parental care and maternal overprotection. Acta Psychiatr Scand. 2002 Aug;106(2):126-33. [PubMed: 12121210]

38.

Luntz BK, Widom CS. Antisocial personality disorder in abused and neglected children grown up. Am J Psychiatry. 1994 May;151(5):670-4. [PubMed: 8166307]

39.

Egami Y, Ford DE, Greenfield SF, Crum RM. Psychiatric profile and sociodemographic characteristics of adults who report physically abusing or neglecting children. Am J Psychiatry. 1996 Jul;153(7):921-8. [PubMed: 8659615]

40.

Brewer AJ, Saunders R, Fearon P, Fonagy P, Cottrell D, Kraam A, Pilling S, Simes E, Anokhina A, Butler S. Antisocial cognition as a mediator of the peer influence effect and peer selection effect in antisocial adolescents. Eur Child Adolesc Psychiatry. 2022 Jan;31(1):177-187. [PMC free article: PMC8816781] [PubMed: 33330952]

41.

Monahan KC, Steinberg L, Cauffman E. Affiliation with antisocial peers, susceptibility to peer influence, and antisocial behavior during the transition to adulthood. Dev Psychol. 2009 Nov;45(6):1520-30. [PMC free article: PMC2886974] [PubMed: 19899911]

42.

Shao R, Wang Y. The Relation of Violent Video Games to Adolescent Aggression: An Examination of Moderated Mediation Effect. Front Psychol. 2019;10:384. [PMC free article: PMC6394371] [PubMed: 30846962]

43.

Wiegman O, van Schie EG. Video game playing and its relations with aggressive and prosocial behaviour. Br J Soc Psychol. 1998 Sep;37 ( Pt 3):367-78. [PubMed: 9738313]

44.

Chen MJ, Miller BA, Grube JW, Waiters ED. Music, substance use, and aggression. J Stud Alcohol. 2006 May;67(3):373-81. [PMC free article: PMC5066304] [PubMed: 16608146]

45.

Moran P. The epidemiology of antisocial personality disorder. Soc Psychiatry Psychiatr Epidemiol. 1999 May;34(5):231-42. [PubMed: 10396164]

46.

Black DW, Gunter T, Loveless P, Allen J, Sieleni B. Antisocial personality disorder in incarcerated offenders: Psychiatric comorbidity and quality of life. Ann Clin Psychiatry. 2010 May;22(2):113-20. [PubMed: 20445838]

47.

Grant BF, Hasin DS, Stinson FS, Dawson DA, Chou SP, Ruan WJ, Pickering RP. Prevalence, correlates, and disability of personality disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2004 Jul;65(7):948-58. [PubMed: 15291684]

48.

Compton WM, Conway KP, Stinson FS, Colliver JD, Grant BF. Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2005 Jun;66(6):677-85. [PubMed: 15960559]

49.

Neumann CS, Hare RD. Psychopathic traits in a large community sample: links to violence, alcohol use, and intelligence. J Consult Clin Psychol. 2008 Oct;76(5):893-9. [PubMed: 18837606]

50.

Simonoff E, Elander J, Holmshaw J, Pickles A, Murray R, Rutter M. Predictors of antisocial personality. Continuities from childhood to adult life. Br J Psychiatry. 2004 Feb;184:118-27. [PubMed: 14754823]

51.

Raine A. Autonomic nervous system factors underlying disinhibited, antisocial, and violent behavior. Biosocial perspectives and treatment implications. Ann N Y Acad Sci. 1996 Sep 20;794:46-59. [PubMed: 8853591]

52.

Dolan M. Psychopathy--a neurobiological perspective. Br J Psychiatry. 1994 Aug;165(2):151-9. [PubMed: 7953028]

53.

Raine A, Venables PH, Williams M. Relationships between central and autonomic measures of arousal at age 15 years and criminality at age 24 years. Arch Gen Psychiatry. 1990 Nov;47(11):1003-7. [PubMed: 2241502]

54.

Moffitt TE, Lynam D. The neuropsychology of conduct disorder and delinquency: implications for understanding antisocial behavior. Prog Exp Pers Psychopathol Res. 1994:233-62. [PubMed: 8044205]

55.

Dolan MC. What imaging tells us about violence in anti-social men. Crim Behav Ment Health. 2010 Jul;20(3):199-214. [PubMed: 20549783]

56.

Goyer PF, Andreason PJ, Semple WE, Clayton AH, King AC, Compton-Toth BA, Schulz SC, Cohen RM. Positron-emission tomography and personality disorders. Neuropsychopharmacology. 1994 Feb;10(1):21-8. [PubMed: 8179791]

57.

Raine A, Lencz T, Bihrle S, LaCasse L, Colletti P. Reduced prefrontal gray matter volume and reduced autonomic activity in antisocial personality disorder. Arch Gen Psychiatry. 2000 Feb;57(2):119-27; discussion 128-9. [PubMed: 10665614]

58.

Robins LN, Price RK. Adult disorders predicted by childhood conduct problems: results from the NIMH Epidemiologic Catchment Area project. Psychiatry. 1991 May;54(2):116-32. [PubMed: 1852846]

59.

Andreasen NC, Rice J, Endicott J, Reich T, Coryell W. The family history approach to diagnosis. How useful is it? Arch Gen Psychiatry. 1986 May;43(5):421-9. [PubMed: 3964020]

60.

Black DW, Baumgard CH, Bell SE. The long-term outcome of antisocial personality disorder compared with depression, schizophrenia, and surgical conditions. Bull Am Acad Psychiatry Law. 1995;23(1):43-52. [PubMed: 7599370]

61.

Dinwiddie SH, Cottler L, Compton W, Abdallah AB. Psychopathology and HIV risk behaviors among injection drug users in and out of treatment. Drug Alcohol Depend. 1996 Dec 02;43(1-2):1-11. [PubMed: 8957138]

62.

Goldstein RB, Dawson DA, Chou SP, Ruan WJ, Saha TD, Pickering RP, Stinson FS, Grant BF. Antisocial behavioral syndromes and past-year physical health among adults in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2008 Mar;69(3):368-80. [PMC free article: PMC2958062] [PubMed: 18348594]

63.

Ellis D, Collis I, King M. Personality disorder and sexual risk taking among homosexually active and heterosexually active men attending a genito-urinary medicine clinic. J Psychosom Res. 1995 Oct;39(7):901-10. [PubMed: 8636922]

64.

Henry BF. Treating Gang-Involved Patients: Embodied Trauma & How to Heal from Life on the Street. Prof Dev (Phila). 2019 Fall;22(2):3-10. [PMC free article: PMC7310987] [PubMed: 32577076]

65.

Raspa RF, Cusack J. Psychiatric implications of tattoos. Am Fam Physician. 1990 May;41(5):1481-6. [PubMed: 2333825]

66.

Clark LA. Assessment and diagnosis of personality disorder: perennial issues and an emerging reconceptualization. Annu Rev Psychol. 2007;58:227-57. [PubMed: 16903806]

67.

Campbell K, Clarke KA, Massey D, Lakeman R. Borderline Personality Disorder: To diagnose or not to diagnose? That is the question. Int J Ment Health Nurs. 2020 Oct;29(5):972-981. [PubMed: 32426937]

68.

Dao TK, Prevatt F, Horne HL. Differentiating psychotic patients from nonpsychotic patients with the MMPI-2 and Rorschach. J Pers Assess. 2008 Jan;90(1):93-101. [PubMed: 18444100]

69.

Sellbom M, Ben-Porath YS, Lilienfeld SO, Patrick CJ, Graham JR. Assessing psychopathic personality traits with the MMPI-2. J Pers Assess. 2005 Dec;85(3):334-43. [PubMed: 16318573]

70.

Falkenbach DM, Reinhard EE, Zappala M. Identifying Psychopathy Subtypes Using a Broader Model of Personality: An Investigation of the Five Factor Model Using Model-Based Cluster Analysis. J Interpers Violence. 2021 Aug;36(15-16):7161-7184. [PubMed: 30827139]

71.

Frick PJ. Early Identification and Treatment of Antisocial Behavior. Pediatr Clin North Am. 2016 Oct;63(5):861-71. [PubMed: 27565364]

72.

Weinberg I, Ronningstam E. Dos and Don'ts in Treatments of Patients With Narcissistic Personality Disorder. J Pers Disord. 2020 Mar;34(Suppl):122-142. [PubMed: 32186986]

73.

Bateman A, O'Connell J, Lorenzini N, Gardner T, Fonagy P. A randomised controlled trial of mentalization-based treatment versus structured clinical management for patients with comorbid borderline personality disorder and antisocial personality disorder. BMC Psychiatry. 2016 Aug 30;16(1):304. [PMC free article: PMC5006360] [PubMed: 27577562]

74.

Khalifa NR, Gibbon S, Völlm BA, Cheung NH, McCarthy L. Pharmacological interventions for antisocial personality disorder. Cochrane Database Syst Rev. 2020 Sep 03;9(9):CD007667. [PMC free article: PMC8094881] [PubMed: 32880105]

75.

Coccaro EF, Kavoussi RJ. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry. 1997 Dec;54(12):1081-8. [PubMed: 9400343]

76.

Müller-Oerlinghausen B, Lewitzka U. Lithium reduces pathological aggression and suicidality: a mini-review. Neuropsychobiology. 2010;62(1):43-9. [PubMed: 20453534]

77.

Barratt ES, Stanford MS, Felthous AR, Kent TA. The effects of phenytoin on impulsive and premeditated aggression: a controlled study. J Clin Psychopharmacol. 1997 Oct;17(5):341-9. [PubMed: 9315984]

78.

Huband N, Ferriter M, Nathan R, Jones H. Antiepileptics for aggression and associated impulsivity. Cochrane Database Syst Rev. 2010 Feb 17;2010(2):CD003499. [PMC free article: PMC4163499] [PubMed: 20166067]

79.

Stanford MS, Helfritz LE, Conklin SM, Villemarette-Pittman NR, Greve KW, Adams D, Houston RJ. A comparison of anticonvulsants in the treatment of impulsive aggression. Exp Clin Psychopharmacol. 2005 Feb;13(1):72-7. [PubMed: 15727506]

80.

Corrigan PW, Yudofsky SC, Silver JM. Pharmacological and behavioral treatments for aggressive psychiatric inpatients. Hosp Community Psychiatry. 1993 Feb;44(2):125-33. [PubMed: 8432495]

81.

Cowdry RW, Gardner DL. Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Arch Gen Psychiatry. 1988 Feb;45(2):111-9. [PubMed: 3276280]

82.

Diamond D, Yeomans F, Keefe JR. Transference-Focused Psychotherapy for Pathological Narcissism and Narcissistic Personality Disorder (TFP-N). Psychodyn Psychiatry. 2021 Summer;49(2):244-272. [PubMed: 34061655]

83.

Kernberg OF. An overview of the treatment of severe narcissistic pathology. Int J Psychoanal. 2014 Oct;95(5):865-88. [PubMed: 24902768]

84.

Ritter S, Platt LM. What's New in Treating Inpatients With Personality Disorders?: Dialectical Behavior Therapy and Old-Fashioned, Good Communication. J Psychosoc Nurs Ment Health Serv. 2016 Jan;54(1):38-45. [PubMed: 26760134]

85.

Sansone RA, Sansone LA. Responses of mental health clinicians to patients with borderline personality disorder. Innov Clin Neurosci. 2013 May;10(5-6):39-43. [PMC free article: PMC3719460] [PubMed: 23882440]

86.

Parth K, Datz F, Seidman C, Löffler-Stastka H. Transference and countertransference: A review. Bull Menninger Clin. 2017 Spring;81(2):167-211. [PubMed: 28609147]

87.

Knaak S, Mantler E, Szeto A. Mental illness-related stigma in healthcare: Barriers to access and care and evidence-based solutions. Healthc Manage Forum. 2017 Mar;30(2):111-116. [PMC free article: PMC5347358] [PubMed: 28929889]

88.

Edershile EA, Wright AGC. Fluctuations in grandiose and vulnerable narcissistic states: A momentary perspective. J Pers Soc Psychol. 2021 May;120(5):1386-1414. [PMC free article: PMC8060359] [PubMed: 33090821]

89.

Scott KM, de Vries YA, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Bromet EJ, Bunting B, Caldas-de-Almeida JM, Cía A, Florescu S, Gureje O, Hu CY, Karam EG, Karam A, Kawakami N, Kessler RC, Lee S, McGrath J, Oladeji B, Posada-Villa J, Stein DJ, Zarkov Z, de Jonge P., World Mental Health Surveys collaborators. Intermittent explosive disorder subtypes in the general population: association with comorbidity, impairment and suicidality. Epidemiol Psychiatr Sci. 2020 Jun 23;29:e138. [PMC free article: PMC7327434] [PubMed: 32638683]

90.

Bateman A, Fonagy P. Comorbid antisocial and borderline personality disorders: mentalization-based treatment. J Clin Psychol. 2008 Feb;64(2):181-94. [PubMed: 18186112]

91.

Jemal M, Tessema W, Agenagnew L. Cluster B personality disorders and its associated factors among psychiatric outpatients in Southwest Ethiopia: institutional-based cross-sectional study. BMC Psychiatry. 2022 Jul 26;22(1):500. [PMC free article: PMC9315846] [PubMed: 35883168]

92.

Trull TJ, Widiger TA. Dimensional models of personality: the five-factor model and the DSM-5. Dialogues Clin Neurosci. 2013 Jun;15(2):135-46. [PMC free article: PMC3811085] [PubMed: 24174888]

93.

Black DW. The Natural History of Antisocial Personality Disorder. Can J Psychiatry. 2015 Jul;60(7):309-14. [PMC free article: PMC4500180] [PubMed: 26175389]

94.

Black DW, Monahan P, Baumgard CH, Bell SE. Predictors of long-term outcome in 45 men with antisocial personality disorder. Ann Clin Psychiatry. 1997 Dec;9(4):211-7. [PubMed: 9511944]

95.

Burt SA, Donnellan MB, Humbad MN, Hicks BM, McGue M, Iacono WG. Does marriage inhibit antisocial behavior?: An examination of selection vs causation via a longitudinal twin design. Arch Gen Psychiatry. 2010 Dec;67(12):1309-15. [PMC free article: PMC3057675] [PubMed: 21135331]

96.

Boot K, Wiebenga JXM, Eikelenboom M, van Oppen P, Thomaes K, van Marle HJF, Heering HD. Associations between personality traits and suicidal ideation and suicide attempts in patients with personality disorders. Compr Psychiatry. 2022 Jan;112:152284. [PubMed: 34763292]

97.

De Wit-De Visser B, Rijckmans M, Vermunt JK, van Dam A. Pathways to antisocial behavior: a framework to improve diagnostics and tailor therapeutic interventions. Front Psychol. 2023;14:993090. [PMC free article: PMC9947159] [PubMed: 36844347]

98.

Cramer V, Torgersen S, Kringlen E. Personality disorders and quality of life. A population study. Compr Psychiatry. 2006 May-Jun;47(3):178-84. [PubMed: 16635645]

99.

James J. Dealing with drug-seeking behaviour. Aust Prescr. 2016 Jun;39(3):96-100. [PMC free article: PMC4919169] [PubMed: 27346918]

100.

Collins TN, Avondoglio JB, Terry LM. Correctional psychopharmacology: pitfalls, challenges, and victories of prescribing in a correctional setting. Int Rev Psychiatry. 2017 Feb;29(1):34-44. [PubMed: 27670976]

101.

Apeldoorn S, Chavez R, Haschemi F, Elsherif K, Weinstein D, Torrico T. Worsening psychosis associated with administrations of buspirone and concerns for intranasal administration: A case report. Front Psychiatry. 2023;14:1129489. [PMC free article: PMC9981973] [PubMed: 36873224]

102.

Mezher AW, McKnight CA, Caplan JP. Buspirone Abuse: No Safe Haven. Psychosomatics. 2019 Sep-Oct;60(5):534-535. [PubMed: 30685117]

103.

Stassinos GL, Klein-Schwartz W. Bupropion "Abuse" Reported to US Poison Centers. J Addict Med. 2016 Sep-Oct;10(5):357-62. [PubMed: 27504927]

104.

Stall N, Godwin J, Juurlink D. Bupropion abuse and overdose. CMAJ. 2014 Sep 16;186(13):1015. [PMC free article: PMC4162783] [PubMed: 24778361]

105.

Jahnsen JA, Widnes SF, Schjøtt J. Quetiapine, Misuse and Dependency: A Case-Series of Questions to a Norwegian Network of Drug Information Centers. Drug Healthc Patient Saf. 2021;13:151-157. [PMC free article: PMC8312250] [PubMed: 34321931]

106.

Sansone RA, Sansone LA. Is seroquel developing an illicit reputation for misuse/abuse? Psychiatry (Edgmont). 2010 Jan;7(1):13-6. [PMC free article: PMC2848462] [PubMed: 20386631]

Disclosure: Tyler Torrico declares no relevant financial relationships with ineligible companies.

Disclosure: Manassa Hany declares no relevant financial relationships with ineligible companies.